AQR Arbitrage’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-168,421
Closed -$6.23M 340
2016
Q4
$6.23M Sell
168,421
-233,700
-58% -$8.35M 0.06% 172
2016
Q3
$13.9M Sell
402,121
-107,595
-21% -$3.77M 0.14% 142
2016
Q2
$16.6M Hold
509,716
0.18% 126
2016
Q1
$14.6M Buy
509,716
+258,743
+103% +$6.89M 0.17% 125
2015
Q4
$8.38M Buy
+250,973
New +$7.8M 0.09% 161

Other funds holding AVNS

AQR Arbitrage's AVNS Position: Q1 2017 in Review

AQR Arbitrage sold out of Avanos Medical (AVNS) in Q1 2017, closing a stake of 168,421 shares — an estimated $6.23M sold.

AQR Arbitrage first reported a position in AVNS in Q4 2015 and held it in 5 quarters. The position peaked at $16.6M in Q2 2016. 335 funds tracked by Wall St. Rank hold AVNS as of Q1 2017.

  • AQR Arbitrage reported no remaining Avanos Medical position as of Q1 2017 after selling out during the quarter.
  • AQR Arbitrage sold 168,421 Avanos Medical shares in Q1 2017, an estimated $6.23M.
  • AQR Arbitrage first reported a position in Avanos Medical in Q4 2015 and held it in 5 quarters.
  • AQR Arbitrage's Avanos Medical position peaked at $16.6M in Q2 2016.
  • 335 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2017.

Based on AQR Arbitrage's 13F filing for Q1 2017, filed 15 May 2017.